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A B S T R A C T  
Objective: To compare the efficacy of prophylactic administration of Ondansetron before induction of spinal 
anesthesia with placebo, in preventing spinal induced hypotension. 
Patients and Methods: This Randomized Control trial was carried out at Holy Family Hospital, Rawalpindi from 29 April 
2015 till 28 October 2015. A total of 106 patients were enrolled in the study. Patients in group A, received 6 mg 
Ondansetron. Patients in group B received normal saline. Mean arterial pressure (MAP) and heart rate (HR) were 
recorded every 5 minutes after performing spinal anesthesia. The study drug was considered efficacious if absence of 
hypotension for 20 minutes was recorded after inducing spinal anaesthesia. Data was analyzed using SPSS 17. 
Results: Hypotension occurred in 7.5% cases in Ondansetron group compared to 28.3% in normal saline 
group (p=0.005). 
Conclusion: Ondansetron is effective in preventing spinal induced hypotension. 
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I n t r o d u c t i o n  
 
Spinal anesthesia remains a popular method of 
anesthesia for a wide range of surgeries due to its 
efficacy, simplicity, safety, advent of newer drugs with 
reduced side effects and more benefits for certain patient 
populations.1 Its numerous advantages include blockade 
of the surgical stress response, decreased intraoperative 
blood loss and transfusion requirements, lower incidence 
of venous thromboembolism and reduced morbidity and 
mortality in high-risk patients.2 However, it is also 
frequently associated with undesirable effects such as 
hypotension, bradycardia, and shivering.3 Hypotension is 
the most common side effect of spinal anesthesia with a 
reported incidence as high as 33% in non-obstetric and 
60% in obstetric, non-laboring patients.Error! Bookmark 
not defined. Symapthectomy induced decreased 
systemic vascular resistance and reduced preload 
secondary to vasodilatation in the lower body are the 
major mechanisms for this hypotension.3 Relative 
dominance of parasympathetic system, activation of 
Bezold Jarish reflex (BJR) and increased baroreceptor 
activity are also contributory factors.Error! Bookmark not 
defined.  In the setting of decreased blood volume, 
serotonin may be an important factor inducing the Bezold 
Jarisch reflex via 5-HT3 receptors located in intracardiac 
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vagal nerve endings, leading to bradycardia and 
hypotension.5 Hemodynamic changes after spinal block 
are usually benign, but they may lead to serious 
consequences such as myocardial ischemia and 
increased stroke risk in certain population groups.6 In 
caesarean sections, hypotension results in decreased 
uteroplacental blood flow, detrimental effects on the fetus 
and maternal nausea vomiting.Error! Bookmark not 
defined. Various strategies employed to prevent spinal-
induced hypotension include fluid preloading and co-
loading, prophylactic administration of vasopressors e.g. 
epinephrine, Trendelenburg positioning, use of lower dose 
of bupivacaine for subarachnoid block.Error! Bookmark 
not defined. Administering fluids, vasopressors and 
anticholinergics for the treatment and prevention of 
hypotension and bradycardia can result in fluid overload, 
hypertension and tachycardia, which may be poorly 
tolerated in elderly and coronary artery disease patients.7  
Furthermore, administration of vasoconstrictors may have 
adverse effects on uterine blood flow in pregnant women. 
Ondansetron, a selective 5-hydroxytryptamine3 (5-HT3) 
receptor antagonist, is an effective antiemetic drug used 
for the prevention and treatment of chemotherapy 
induced, intraoperative and postoperative nausea and 
vomiting.8 Prophylactic administration of Ondansetron has 
been reported to have a perioperative anti-shivering effect 
in patients under anesthesia. Recently, it has also been 
demonstrated to be effective in preventing spinal induced 
hypotension in multiple studies, possibly by preventing 
serotonin-induced Bezold-Jarisch reflex (BJR), 
suppressing venodilatation and augmenting venous 
return.9 
In a study conducted in Iran by Marashi et al, 12 (17%) 
patients in the control group had MAP (Mean arterial 
pressure) < 80 mm Hg and required vasopressors 
compared to 0 patients in Ondansetron groups. (P = 
0.04).3 Owczuk R. et al demonstrated that the minimum 
diastolic and mean blood pressure values obtained over a 
20-minute observation period after spinal anesthesia were 
significantly higher in the Ondansetron group compared to 
the control group.9 However, none of these studies has 
been conducted in Pakistan. The basic aim of our study 
was to look for the effect of prophylactic Ondansetron 
administration on spinal induced hypotension in our 
population, so that Ondansetron if found to be effective, 
may be routinely used for the prevention of hypotension 
after spinal anesthesia in elective surgeries. 
P a t i e n t s  a n d  M e t h o d s  
This Randomized Control trial was carried out at Holy 
Family Hospital, Rawalpindi from 29 April 2015 till 28 
October, 2015. A total of 106 admitted elective patients 
were included in the study. American society of 
anesthesiologist’s classification I and II between the ages 
of 20-50 years who presented for elective urologic, 
orthopedic or gynecologic surgeries were included in the 
study. Exclusion criteria included, patient refusal or any 
contraindications to spinal anesthesia, any allergy to 
Ondansetron or local anesthetics and comorbid conditions 
like hypertension, coronary artery disease or other 
cardiovascular diseases, diabetes mellitus, pulmonary, 
hepatic or renal diseases. Patients receiving selective 
serotonin reuptake inhibitors or migraine medications or 
obesity BMI >35 were also excluded from the study. 
After obtaining approval from hospital ethical committee 
and written informed consent, patients were recruited 
according to selection criteria. All patients were assessed 
a day before surgery for anesthesia fitness. Patients were 
prepared by fasting (8 h for solid foods, 4 hours for clear 
fluids). Patients were randomly divided into two equal 
groups (Group A and Group B) by computer-generated 
random numbers. On arrival to the operating room, 
standard monitor was applied to all patients, including 
pulse oximeter, electrocardiogram and noninvasive 
arterial blood pressure. Oxygen was delivered via a 
Venturi facemask at a rate of 4 L/min. An 18-gauge 
intravenous catheter was placed and patients received 5 
ml/kg lactated Ringer solution over 15 minutes before 
spinal Anesthesia. Then patients in Group-A was given 6 
mg Ondansetron diluted in normal saline to 20 ml. The 
patients in the control group (Group-B) received 20 ml 
normal saline. In both groups, solutions were infused over 
5 minutes just before performing spinal anesthesia. All 
solutions were prepared by a resident of anesthesiology 
who was not involved in patient’s management or data 
collection. Baseline parameters (including heart rate, 
MAP) were recorded 5 minutes prior to induction of spinal 
anesthesia. Subarachnoid block was performed in the 
lateral position with a 25-gauge needle inserted by midline 
approach into the L3-4 interspace. After ensuring the 
correct position of the needle, 15 mg of 0.75% hyperbaric 
                            210 JIMDC  2017  210 
bupivacaine was injected. Patients were immediately 
placed in the supine position after spinal block. The upper 
level of sensory blockade was evaluated by pinprick test 
from caudal to rostral direction at 5-min intervals up to 20 
minutes. MAP and HR were recorded every 5 minutes up 
to 20 minutes by an anesthesiologist blinded to the study 
groups. If MAP dropped <80 mm Hg or decreased more 
than 20% from baseline, 50 micrograms intravenous 
Phenylephrine was given, and repeated if necessary. 
Significant bradycardia (heart rate < 50 beats/min) 
accompanied by hypotension was treated with 0.5 mg of 
intravenous Atropine. 
Data was collected on a standardized performa and 
analyzed using SPSS version 17. Mean±SD was 
calculated for quantitative variables like age, weight, BMI, 
and MAP. Qualitative variables like gender and 
hypotension were expressed as frequencies and 
percentages. Chi-square test was used to compare the 
incidence of hypotension in the two groups. Effect 
modifiers like age, gender and indication for surgery were 
controlled by stratification. Post stratification Chi -Square 
test was applied. p value <0.05 was considered 
statistically significant.  
R e s u l t s  
Demographic characteristics of both group have been 
given in table 1. Hypotension occurred in 17.92% patients 
in our study. In the Ondansetron group, hypotension was 
observed in 7.5% of cases. In the normal saline group, 
28.3% of patients had hypotension.  
Frequency of hypotension was significantly lower in the 
Ondansetron group as compared to placebo group (Table 
2). There was no significant difference in the MAP of both 
groups at all times (table 3). Regarding gender, among 
females’ frequency of hypotension was lower in the 
Ondansetron group as compared to placebo but the 
difference was not statistically significant among males 
(Table 4).  
 
Table 1: Comparison of demographic characters 
between two groups (n=106) 
Variables Ondansetron 
group (n=53) 
Placebo group 
(n=53) 
p-value 
Age 
(Years); 
mean±SD 
34.45 ± 1.24 34.98 ± 0.96 0.10 
Weight 
(kg); 
mean±SD 
65.15 ± 1.37 72.58 ± 1.20 0.16 
BMI 
(kg/m2); 
mean±SD 
23.99 ± 0.44 25.97 ± 0.48 0.48 
Gender; n 
(%) Male       
Female 
 
27(44) 
26(58) 
 
34(56) 
19(42) 
 
0.16 
Table 2: Frequency of hypotension between 
Ondansetron and placebo groups 
Groups Hypertension 
Yes No p-value 
n n(%) n n(%) 
Ondansetron 4 7.5 49 92.5  
.005 Placebo  15 28.3 38 71.7 
Table 3: Mean Arterial Pressure in Ondansetron and 
Placebo groups 
Variable Ondansetron 
group (n=53) 
mean±SD 
Placebo 
group (n=53) 
mean±SD 
p-value 
MAP at 
Baseline (5 
minutes 
before 
spinal 
anesthesia) 
106.28 ± 0.98 104.54 ± .96 0.94 
MAP 5 
minutes 
after spinal 
Anesthesia 
97.77 ± 0.94 93.17 ± 1.44 0.08 
MAP 10 
minutes 
after spinal 
anesthesia 
93.77 ± 0.94 89.51 ± 1.28 0.20 
MAP 15 
minutes 
after spinal 
anesthesia 
90.26 ± 0.81 85.92 ± 1.15 0.31 
MAP 20 
minutes 
after spinal 
anesthesia 
86.74 ± 0.75 82.17 ± 0.99 0.07 
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There was statistically significant difference in the 
frequency of hypotension between Ondansetron and 
placebo groups in urologic surgeries, but the difference 
between the two groups was insignificant in orthopedic 
and gynecologic surgeries (Table 5). Difference in 
frequency of hypotension was also statistically significant 
between Ondansetron and placebo groups in patients 
belonging to 20-40 years of age, but the difference was 
insignificant in age group 41-50 years (Table 6).  
 
Table 5: Comparison of hypotension between 
Ondansetron and placebo groups stratified by 
indication for surgery (n=106) 
Indications 
for Surgery 
Groups Hypotension p-value 
Yes 
n(%) 
No 
n(%) 
Orthopedic Ondansetron 
Group (n=22) 
2(9) 20(91) 0.06 
Placebo 
Group (n=22) 
7(32) 15(68) 
Urologic Ondansetron 
Group (n=20) 
0(0) 20(100) 0.03 
Placebo 
Group (n=20) 
4(20) 16(80) 
Gynaecologic Ondansetron 
Group (n=11) 
2(18) 9(82) 0.34 
Placebo 
Group(n=11) 
4(36) 7(64) 
Table 6: Comparison of hypotension between 
Ondansetron and placebo groups stratified by age 
of patients 
Age 
groups 
(years) 
Groups Hypotension p-value 
Yes 
n(%) 
No    
n(%) 
20 – 30 Ondansetron 
Group (n=19) 
0(0) 19(100) 0.012 
Placebo 
Group (n=14) 
4(29) 10(71) 
31 – 40 Ondansetron 
Group (n=19) 
1(5) 18(95) 0.029 
Placebo 
Group (n=25) 
8(32) 17(68) 
41 – 50 Ondansetron 
Group (n=15) 
3(20) 12(80) 0.924 
Placebo 
Group (n=14) 
3(21) 11(79) 
D i s c u s s i o n  
It is frequently observed that spinal anesthesia produces 
hemodynamic effects. The most frequent of these is 
hypotension and bradycardia. Hypotension occurs as a 
result of vasodilatation secondary to sympathetic 
blockade. Sympathetic blockade spreads two segments 
higher than the sensory blockade, which in turn spreads 
two segments higher than the motor blockade. 
Vasodilatation causes decrease in systemic vascular 
resistance and central venous pressure.9-12 The same 
mechanism can sometimes lead to bradycardia. Main 
causes of bradycardia are shift in cardiac autonomic 
balance toward the parasympathetic system, activation of 
left ventricular mechanoreceptors from a sudden 
decrease in left ventricular volume (Bezold-Jarisch reflex) 
(BJR). It is suggested by pharmacological and animal 
studies that an important factor in initiating the BJR is 5- 
HT (serotonin) and blockade of 5-HT3 receptor can lead 
to attenuation of this reflex.6 
It was shown by previous studies that Ondansetron 4 mg 
of Ondansetron administration has been occasionally 
used to decrease maternal hypotension and nausea.9 
Spinal anesthesia is the preferred anesthetic technique 
Table 4: Comparison of hypotension between 
Ondansetron and placebo groups stratified by 
gender (n=106) 
Gender Groups Hypotension p-value 
Yes 
n(%) 
No      
n(%) 
Male Ondansetron 
Group (n=27) 
2(7) 25(93)  
0.09 Placebo 
Group (n=34) 
8(24) 26(76) 
Female Ondansetron 
Group (n=26) 
2(8) 24(92)  
 
0.02 
Placebo 
Group (n=19) 
7(37) 12(63) 
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for caesarean section as it is simple, safe, fast and 
reliable technique could effectively prevent maternal 
hypotension and nausea secondary to spinal anesthesia. 
Fetal morbidity increases by the decrease in cardiac 
output and uteroplacental flow caused by hypotension 
due to spinal anesthesia.2   A very high sensory block 
requirement (till T5) in caesarean section causes 
extensive sympathetic blockade and hypotension in 55 to 
90% of cases. Maneuvers like the partial left lateral 
decubitus (with the objective of limiting the aorto-caval 
compression caused by the gravid uterus) are partially 
effective. Vascular filling with crystalloids or starches and 
use of vasopressors are mainly used to treat hypotension 
but many studies showed these methods ineffective. It 
was shown by a recent review that hypotension is not 
prevented reliably by any one of these methods. To 
decrease fetal and maternal morbidity and mortality 
during spinal anaesthesia, it is crucial to prevent and treat 
it effectively. Ondansetron can be routinely used to 
prevent maternal hypotension and fetal compromise after 
spinal anesthesia in caesarean sections, as well as 
general surgical and other procedures performed in spinal 
anesthesia. It can be a good alternative for previously 
used methods to treat spinal induced hypotension. 
Ondansetron does not affect the heart and blood 
pressure, even when it is rapidly administered 
intravenously. In both children and adults, this drug is 
widely used to prevent postoperative nausea and vomiting 
prevention.  
Based on above mentioned considerations, we conducted 
this randomized, controlled, double-blind study, that use 
of intravenous Ondansetron can be investigated and it 
can be used prophylactically for spinal induced 
hypotension. A total of 106 patients were enrolled in the 
study and were randomly divided into two equal groups. 
Hypotension occurred in 17.92% of patients in our study. 
The frequency of hypotension was significantly lower in 
the Ondansetron group (7.5%) as compared to placebo 
(28.3%). In a study conducted by Owczuk R et al,Error! 
Bookmark not defined.  two equal groups were made 
out of 53 patients who operated under spinal anesthesia. 
It was observed that 48.1% patients in placebo group and 
38.5% patients in onset group developed hypotension. 
They made the conclusion that Ondansetron is effective in 
preventing decrease in MAP and HR when compared to 
normal saline group. Their results were comparable to 
those observed in our study. In our study, we compared 
Ondansetron 6 mg with placebo. Owczuk et al. compared 
Ondansetron 8 mg with placebo. Sahoo et al. compared 
Ondansetron 4 mg with placebo.5 Marashi et al. 
compared Ondansetron 6mg and 12mg with placebo.3 
Ortiz-Gómez et al.’s study 10 included three doses of 
Ondansetron (2, 4, and 8 mg versus placebo). Owczuk et 
al. and Marashi et al. studied a general surgical 
population. Sahoo et al. and Ortiz-Gómez et al used 
obstetric patients in their study. We on the other hand, 
studied patients undergoing urological, orthopedic and 
gynecological surgeries. 
Anesthetic technique and dose is a very important factor 
that can cause the difference between the studies. A 
different dose of hyperbaric bupivacaine was used in all of 
these above-mentioned studies. We and Marashi et al. 
used 15mg of hyperbaric bupivacaine for spinal 
anesthesia. Sahoo et al. used 10 mg bupivacaine, 
Owczuk et al used 20 mg bupivacaine. Ortiz-Gómez et al. 
personalized each dose to each patient (9.7 ± 0.4 mg in 
the placebo group and 9.6 ± 0.3 mg in Ondansetron 
group), and the mean dose was smaller than our dose of 
15mg. This was a good method as it can be used to 
prevent over or under dosing of patients. Another 
difference is that intravenous fentanyl to treat pain and 
tramadol or promethazine to treat adverse effects was 
used by Sahoo et al. Blood pressure readings can be 
modified directly or indirectly by these medications due to 
a central mechanism. Another difference is that we do not 
use intrathecal opioids for improving effect of spinal 
anesthesia. This is different from the study of Ortiz- 
Gómez et al. in which intrathecal fentanyl was used. 
Ondansetron may be centrally acting and its mechanism 
can be affected by intrathecal opioids. Neither we nor 
Ortiz-Gómez et al used other supplemental analgesia, 
and patients who required it were not included in the 
study. Earlier studies have suggested that when 
Ondansetron is administered intravenously, it can 
antagonize sensory block produced by local anesthetics 
given intrathecally. This is perhaps the reason for the 
attenuated hemodynamic responses after spinal 
anesthesia. 
To summarize, in the current study, we investigated the 
effects of 6 mg of Ondansetron on the patients’ MAP. We 
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observed that 6 mg of Ondansetron intravenous, when 
given alongside rapid crystalloid infusion, could 
significantly reduce the incidence of spinal induced 
hypotension. However, Ondansetron preloading did not 
appear to have any significant effect in reducing 
hypotension in gynecologic and orthopedic surgeries. We 
can assume that 6 mg of Ondansetron may not be 
sufficient to prevent hypotension in these types of 
surgeries. It seems that Ondansetron enhances the 
contractility and efficiency of the heart by acting at cardiac 
level and stabilizes systemic vascular resistance by acting 
at vascular level through vascular and/or medullary 
specific receptors. 
C o n c l u s i o n  
Ondansetron is effective in preventing hypotension in 
patients undergoing spinal anesthesia. 
R e c o m m e n d a t i o n s  
We do feel the need to include other important variables 
like heart rate, systolic and diastolic blood pressures. The 
duration and type of surgery, blood loss and maintenance 
fluid requirements can influence results of such studies. 
Further studies should be carried out, taking into 
consideration these aspects too. Studies should also be 
done that involve more invasive hemodynamic monitoring 
like Swan-Glanz catheter. It can be helpful to properly 
assess decrease in venous return and cardiac filling 
pressures. The effect of different doses of Ondansetron 
on reducing spinal induced hypotension also needs to be 
further investigated. 
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